Objective To assess the functionality and feasibility of the GROWIN app for promoting early
detection of growth disorders in childhood, supporting early interventions, and improving …

Background There are not clear evidence to date evaluating patients' and caregivers'
preferences for the recombinant‐human growth hormone (r‐hGH) injection in children in …

Prompt diagnosis and early treatment are key goals to optimize the outcomes of children
with growth hormone deficiency (GHD) and attain the genetically expected adult height …

Objectives: The aim of the study was to evaluate the efficacy of early initiation versus late
growth hormone in improving the predicted adult height in growth hormone deficiency …

Purpose Adherence to recombinant human growth hormone (r-hGH) is critical to growth and
other outcomes in patients with growth disorders, but the requirement for daily injections …

Background: Growth hormone deficiency (GHD) remains the most common indication for
use of recombinant human growth hormone (rhGH) therapy in clinical practice. However …

Results We enrolled 23 subjects in group I (cases who received GH) and group II (controls
with untreated children), and both the groups were comparable at baseline. Group I …

Results this study showed that all patients had height lower than normal (2 standard
deviation below the mean). Growth hormone deficiency) was the main cause of" short …

Background Short stature is a well-known consequence of Turner's syndrome (TS) and
treatment with growth hormone can be improved the height of those patients, determination …

Background. The significance of this study lies in the fact that short stature is highly prevalent
among children, affecting 1–5% of the population and having diverse causes. The child's …